Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
12.74
-0.17 (-1.32%)
Sep 5, 2025, 4:00 PM - Market closed
Company Description
Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions.
The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.
Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants.
The company was incorporated in 2018 and is based in Carlsbad, California.
Carlsmed, Inc.
| Country | United States |
| Founded | 2018 |
| IPO Date | Jul 23, 2025 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 89 |
| CEO | Michael Cordonnier |
Contact Details
Address: 1800 Aston Avenue, Suite 100 Carlsbad, California 92008 United States | |
| Phone | 760 766 1923 |
| Website | carlsmed.com |
Stock Details
| Ticker Symbol | CARL |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $15.00 |
| CIK Code | 0001794546 |
| Employer ID | 83-1081863 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Michael (Mike) Cordonnier | Chairman, Chief Executive Officer, President, and Co-Founder |
| Leonard (Leo) Greenstein | Chief Financial Officer, Treasurer |
| William (Scott) Durall | Chief Commercial Officer |
| Niall Casey | Co-Founder, Chief Intellectual Property Officer, Secretary, Director |
| Jonathan (Jon) Root, M.D. | Director |
| Robert Mittendorff, M.D. | Director |
| Philip (Phil) Young | Director |
| Kevin Sidow | Director |
| Kevin O’Boyle | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 28, 2025 | 10-Q | Quarterly Report |
| Aug 28, 2025 | 8-K | Current Report |
| Jul 24, 2025 | SCHEDULE 13G | Filing |
| Jul 24, 2025 | 8-K | Current Report |
| Jul 24, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jul 24, 2025 | 424B4 | Prospectus |
| Jul 22, 2025 | EFFECT | Notice of Effectiveness |
| Jul 22, 2025 | CERT | Certification by an exchange approving securities for listing |
| Jul 21, 2025 | 8-A12B | Registration of securities |
| Jul 15, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |